Faegre Drinker advised Boston Scientific, and Latham & Watkins advised Relievant MedSystems on the deal. Boston Scientific Corporation (NYSE: BSX) announced it has entered into a...
Boston Scientific’s $850 Million Acquisition of Relievant MedSystems
e.l.f. Beauty’s US$355 Million Acquisition of Naturium
Latham & Watkins advises e.l.f. Beauty in its acquisition of Naturium. e.l.f. Beauty (NYSE: ELF) has announced it has signed a definitive agreement to acquire Naturium,...
Omada Health’s $80 Million Growth Financing
Latham & Watkins advises Omada Health on growth financing. Omada Health, Inc., a virtual-first healthcare provider that implements clinically-validated behavior change protocols for individuals living with...
Amplitude’s Direct listing of Class A Common Stock
Goodwin advised Morgan Stanley on the deal, while Latham & Watkins represented Amplitude. Amplitude, Inc., a pioneer in digital optimization, announced that, as of September 22, 2021,...
The Cheesecake Factory’s Common Stock Offering
Latham & Watkins LLP represented The Cheesecake Factory, while Paul, Weiss, Rifkind, Wharton & Garrison LLP represented affiliates of Roark Capital in the offering. Simpson Thacher...
The Cheesecake Factory’s $300 Million Convertible Senior Notes Offering
Latham & Watkins LLP represented The Cheesecake Factory, while Paul, Weiss, Rifkind, Wharton & Garrison LLP represented affiliates of Roark Capital in the offering. Simpson Thacher...
Alkami Technology’s $180 Million Initial Public Offering
Latham & Watkins LLP represented Alkami in the offering, Davis Polk advised the representatives of the several underwriters. Alkami Technology, Inc., a leading cloud-based digital banking...